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Cytotoxic T Cell–Resistant Variants Are Selected
in a Virus-Induced Demyelinating Disease
Lecia Pewe,* Gregory F. Wu,‡ Edward M. Barnett,‡ More direct evidence for the role of CTL escape mu-
tants in viral pathogenesis comes from the study ofRaymond F. Castro,† and Stanley Perlman*‡†
model infections in mice. The issue of escape from*Department of Pediatrics
CTL surveillance has been studied most intensively in†Department of Microbiology
mice infected with lymphocytic choriomeningitis virus‡Neuroscience Program
(LCMV). In C57Bl/6 (B6) mice, three LCMV-specific epi-University of Iowa
topes are recognized by CD81 T cells. Infection withIowa City, Iowa 52242
virus in which either two (Moskophidis and Zinkernagel,
1995) or three (Lewicki et al., 1995) of these epitopes
have been mutated so that they are no longer recognized
Summary by CD81 T cells results in a delay in kinetics until the
virus is eliminated. Similar results have been obtained
C57Bl/6 mice infected with mouse hepatitis virus, by in vivo selection of LCMV escape mutants (Pircher
strain JHM (MHV-JHM) develop a chronic demyelinat- et al., 1990). In these experiments, mice transgenic for
ing encephalomyelitis. Infectious virus can be isolated a virus-specific T cell receptor were used since selection
only from symptomatic mice. In C57Bl/6 mice, two for LCMV CTL escape mutants occurs infrequently in
CD81 T cell epitopes within the MHV-JHM surface gly- mice with a normal immune system. This example pro-
coprotein were previously identified. Here, we show vides the only evidence for a clear correlation between,
that mutations in the RNA encoding the immunodomi- on the one hand, the development of CTL escape mu-
nant of the epitopes are present in nearly all virus tants and, on the other hand, increased viral replication
samples isolated from these mice. Mutations are not during the course of a natural infection.
present in sequences flanking this epitope or in other Mouse hepatitis virus, strain JHM (MHV-JHM) causes
CD81 or CD41 T cell epitopes. Furthermore, analysis acute encephalitis and acute and chronic demyelinating
of five peptides corresponding to variant epitopes in encephalomyelitis in susceptible rodents (Kyuwa and
direct ex vivo cytotoxicity assays showed that each Stohlman, 1990; Wege, 1995). The CD81 T cell response
mutation caused a loss of epitope recognition. These to MHV is important for virus control and clearance.
results suggest that escape from CD81 T cell recogni- Depletion of CD81 T cells results in decreased virus
tion is necessary for enhanced virus replication and clearance in MHV-infected mice (Pearce et al., 1994;
development of clinical disease in these MHV-JHM- Williamson and Stohlman, 1990). b2-microglobulin
infected mice. (2/2) mice, defective in major histocompatibility com-
plex (MHC) class I antigen presentation, are exquisitely
sensitive to infection with the mildly neurotropic A59
Introduction strain of MHV (Gombold et al., 1995) or MHV-JHM (un-
published data). Recently, the target for MHV-specific
While the existence of cytotoxic T lymphocyte (CTL) CD81 T cells has been identified in both B6 and BALB/c
escape mutants in many viral infections has been well mice. Two epitopes within the surface glycoprotein (S)
documented, their role as key factors in virus persis- were detected using lymphocytes harvested from the
tence remains controversial (Franco et al., 1995; Mie- brains of B6 mice with acute encephalitis. These cells
dema and Klein, 1996; Nowak and Bangham, 1996; Zink- were partially purified and their specificity was deter-
ernagel, 1996). In human patients infected with the mined in direct ex vivo cytotoxicity assays (Castro and
human immunodeficiency virus type 1 (HIV-1) or chroni- Perlman, 1995). The two epitopes encompassed resi-
cally infected with hepatitis B virus, CTL escape mutants dues 510–518 (S-510–518) and 598–605 (S-598–605) of
arise during the course of the infection (Bertoletti et al., the S protein and were H-2Db- and H-2Kb-restricted,
1994a, 1994b;Franco et al.,1995; Klenermanet al., 1994; respectively. The immunodominant of the two, S-510–
Phillips et al., 1991; Wolinsky et al., 1996). However, in 518, was also recognized when spleen cells were ana-
most cases, several CD81 T cell epitopes within viral lyzed in CTL assays after stimulation in vitro for 5 days
proteins are recognized, and often only one of these or when CD81 T cell clones were prepared and analyzed
epitopes is mutated and no longer recognized (Franco (Bergmann et al., 1996). Epitope S-510–518 is located
et al., 1995). Loss of recognition of a singleepitope under in a region of the S protein known from previous studies
these conditions might not be biologically significant. In to be hypervariable (Adami et al., 1995; Parker et al.,
some cases, the CTL escape mutants do not remain 1989). On the other hand, the immunodominant epitope
predominant even in the presence of an active T cell recognized by CTLs from BALB/c mice is located in the
response to the epitope (Phillips et al., 1991). Therefore, nucleocapsid (N) protein in a sequence not reported to
although CTL escape mutants may contribute to the be hypervariable (Bergmann et al., 1993).
progression of disease in some cases, data supporting Most inbred strains of mice, including B6 mice, de-
their importance in human disease are limited. It has velop an acute, fatal encephalitis after intracerebral or
been suggested that CTL escape mutants are likely to intranasal infection with MHV-JHM. If the initial infection
be most important when the CTL response is strong is modulated either by using an attenuated strain of
and functionally directed to a single epitope (Franco et virus or by passive infusions of anti-virus antibodies or
T cells, mice are protected from fatal encephalitis, butal., 1995; Rehermann et al., 1995).
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may still develop an acute demyelinating encephalomy- in some mice, leucine or glycine at position 3 or 6, re-
spectively, was changed to arginine, whereas in otherselitis (Buchmeier et al., 1984; Dalziel et al., 1986; Fleming
et al., 1989; Haspel et al., 1978; Ko¨rner et al., 1991; the asparagine at position 5, a residue critical for binding
to the H-2Db molecule (Falk et al., 1991; Young et al.,Stohlman et al., 1986, 1995; Yamaguchi et al., 1991).
Viral antigen, but usually not infectious virus, can be 1994), was mutated. This propensity for mutation was
specific for the sequence of epitope S-510–518, sincedetected in these mice. Over time, these mice remain
asymptomatic or slowly regain neurological function. no other changes were observed in the approximately
200 nt flanking the epitope. In no case was wild-typeExceptions to this pattern occur in MHV-infected suck-
ling and weanling rats (Sorensen et al., 1980; Watanabe epitope S-510–518 sequence detected in virus isolated
from mice with hindlimb paralysis in these analyses ofet al., 1987) and insuckling B6 mice infected intranasally
with MHV-JHM and protected from the acute encephali- bulk PCR product. Furthermore, an additional 200 nt
surrounding the H-2Kb-restricted epitope encompass-tis by nursing with dams previously immunized to MHV-
JHM (Perlman et al., 1987). In the latter instance, B6 ing residues 598–605 were sequenced in four isolates.
No changes were detected in this epitope.mice develop the relatively acute onset of hindlimb pare-
sis 3–8 weeks after infection, and this usually progresses
to complete paralysis. This acute presentation of clinical
Mutations in Epitope S-510–518 Are Alsodisease several weeks after virus inoculation does not
Detected in Viral RNA Directly Isolatedoccur in BALB/c mice infected under similar conditions
from Infected Brains and Spinal Cordsor in B6 mice infected later than the suckling stage
Passage through tissue culture cells may select for a(Castro et al., 1994; Sun and Perlman, 1995).
specific subset of viruses present in a heterogeneousSince only B6 mice infected at the suckling stage and
population. This selection as a result of passage throughtreated as described above develop the acute onset of
tissue culture cells has been most clearly demonstratedhindlimb paralysis several weeks after infection, and
in the case of HIV-1 (Meyerhans et al., 1989). To deter-since the immunodominant CD81 T cell epitope was in
mine whether the mutations in epitope S-510–518 de-a hypervariable region of the genome, we reasoned that
scribed above were an artifactof passagethrough tissuechanges in this epitope might occur and lead to CTL
culture cells, we isolated RNA from chronically infectedescape. Such mutations would change the balance of
brains and spinal cords and prepared and sequencedthe infection between the B6 mouse and MHV-JHM,
PCR products as above. As shown in Table 2, epitopeleading to increased viral replication and clinical dis-
S-510–518 was mutated in spinal cord RNA isolatedease. This system, inwhich theCTL response is predom-
from each mouse, and in no two animals was the sameinantly directed at a single epitope, is potentially useful
change observed. As was observed with the mutationsfor testing the hypothesis that CTL escape mutants are
described above, the changes weresignificant and likelymost important in thecontext of a functionally monospe-
to affect recognition of the epitope by CTLs.cific CD81 T cell response.
Direct sequencing of PCR products provides informa-
tion about the predominant sequence present in in-Results
fected spinal cord RNA. To determine whether any het-
erogeneity existed in the population of RNA moleculesEpitope S-510–518 Is Mutated in All Cases
encoding epitope S-510–518 within a single animal, wein Virus Isolated from Mice
prepared cDNA clones from each spinal cord and se-with Hindlimb Paralysis
quenced them as described in Experimental Proce-As reported previously (Perlman et al., 1987, 1990), in-
dures. In each case, the predominant mutation detectedfectious virus is readily isolated from the brains and
was the same as determined by direct PCR sequencespinal cords of mice that develop hindlimb paralysis
analysis (Table 2). Additional mutations, however, wereseveral weeks after inoculation. MHV-JHM harvested
also detected in the epitope within a single animal. Infrom nine B6 mice was passaged for one to three gener-
some animals, a second, minor variant with a differentations in tissue culture cells, and polymerase chain reac-
mutation in the sequence of epitope S-510–518 but lack-tion (PCR) products encompassing the region of the S
ing the predominant mutation was present (e.g., muta-gene that encoded the two CD81 T cell epitopes (nucleo-
tion at nucleotide 1541 in mouse 164). Some clonestides 1325–2118) were prepared as described in Experi-
contained a second mutation in addition to encodingmental Procedures. The amino acid sequence of the
the predominant mutation characteristic of the majorinput virus was identical to the published sequence for
virus variant infecting that mouse (e.g., mutation at nu-this region of the S gene with one exception (phenylala-
cleotide 1534 in mouse 165). For each clone, approxi-nine to leucine at position 539, not contained within
mately 200 nt in the vicinity of epitope S-598–605 waseither epitope) (Parker et al., 1989). Approximately
also sequenced, and in no case were any mutations in200 nt of each PCR product in the region of epitope
this epitope identified. Rare mutations present in singleS-510–518 was directly sequenced and compared with
cDNA clones were detected at other sites. Thesethe sequence of the virus used for the initial infection
changes may have resulted from the high error rate(Table 1). In all cases, epitope S-510–518 was mutated
of the MHV RNA–dependent RNA polymerase or mayfrom the wild-type sequence, and different changes
represent Taq enzyme–related errors that occurred dur-were present in most isolates. Changes were present in
ing the cloning procedure. In another control, a regionat least one of residues 2–7 of the epitope. All of the
of the transmembrane M protein previously shown tochanges were nonsynonymous and resulted in signifi-
cant changes in the amino acid sequence. For example, contain an immunodominant CD41 T cell epitope (Xue
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Table 1. Sequence Analysis of Virus Isolated from Infected CNS Tissue
Mouse (PFU/g)a Dpib Source Mutationc Sequence
Wild type CSLWNGPHL
1 (5.00) 31 SCd 1532 (C to A) CYLWNGPHL
2 (3.69) 28 SC 1535 (T to G) CSRWNGPHL
3 (4.04) 30 SC 1535 (T to G) CSRWNGPHL
4 (3.87) 26 Brain plus SCe 1541 (A to G) CSLWSGPHL
5 (3.19) 23 Brain 1541 (A to G) CSLWSGPHL
6 (3.69) 30 SC 1541 (A to C) CSLWTGPHL
7 NT f 30 SC 1543 (G to A) CSLWNRPHL
8 (5.92) 24 SC 1547 (C to T) CSLWNGLHL
9 (5.54) 27 SC 1531–1536 CFWNGPHL
(TCTCTT to TTT) (SL to F)
a Virus was titered as previously described (Perlman et al., 1987). Titers are expressed as log10 plaque-forming units (PFU) per gram of tissue.
b Day postinfection at which CNS tissue was harvested from mice with hindlimb paralysis.
c Nucleotide change and location within sequence encoding epitope S-510–518 (nucleotides 1528–1554 of S gene).
d SC, spinal cord.
e Brain and spinal cord were combined in this sample.
f NT, not tested.
et al., 1995) was also sequenced. No mutation in this brain. Virus containing mutations in epitope S-510–518
could arise from a single site or from multiple, spatiallyepitope was detected in any clone, although a change
at nucleotide 463, resulting in a change from phenylala- separated sites in the central nervous system (CNS) of
a single animal. If mutant virus arises from multiple sites,nine to leucine, was present in all clones. This change
is not located in the CD41 T cell epitope and is also then in some cases the viral isolates from the brain and
spinal cord might contain different versions of epitopepresent in the A59 strain of MHV (Armstrong et al., 1984).
Disease in these mice is usually most extensive in the S-510–518. There is precedent for this, since indepen-
dent evolution of virus in the brain and spinal cord of aspinal cord, although virus can also be isolated from the
Table 2. Sequence Analysis of RNA Harvested from CNS Tissue of Mice with Hindlimb Paralysis
Number of
Mouse Dpia Source Analysisb Clones/Totalc Mutationd New Sequence
Wild type CSLWNGPHL
162 50 Brain Bulk 1544 (G to T) CSLWNVPHL
162 SCe Bulk 1544 (G to T) CSLWNVPHL
162 SC Clones 10/10 1544 (G to T) CSLWNVPHL
163 23 Brain Bulk No changes detected
163 Brain Clones 5/11 No changes detected
3/11 1541 (A to G) CSLWSGPHL
1/11 1535 (T to C) CSPWNGPHL
1/11 1530 (T to C) CSLRNGPHL
1537 (T to A)
1/11 1537 (T to A) CSLRNGPHL
163 SC Bulk 1537 (T to A) CSLRNGPHL
163 SC Clones 9/11 1537 (T to A) CSLRNGPHL
1/11 1547 (C to T) CSLWNGLHL
1/11 1541 (A to G) CSLWSGLHL
1547 (C to T)
164 58 Brain Bulk 1547 (C to T) CSLWNGLHL
164 SC Bulk 1547 (C to T) CSLWNGLHL
164 SC Clones 7/10 1547 (C to T) CSLWNGLHL
2/10 1541 (A to G) CSLWSGLHL
1547 (C to T)
1/10 1541 (A to G) CSLWSGPHL
165 39 Brain Bulk 1541 (A to G) CSLWSGPHL
165 SC Bulk 1541 (A to G) CSLWSGPHL
165 SC Clones 9/10 1541 (A to G) CSLWSGPHL
1/10 1534 (C to T) CSFWSGPHL
1541 (A to G)
a Day postinfection at which mice developed hindlimb paralysis.
b Sequence of either bulk PCR product (bulk) or cDNA clones prepared from the PCR product (clones).
c Number of clones showing changes over total analyzed.
d Nucleotide change and location within sequence encoding epitope S-510–518 (nucleotides 1528–1554 of S gene).
e SC, spinal cord.
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Table 3. Sequence Analysis of RNA Harvested from Asymptomatic Mice at 60 dpi
Number of
Mouse Source Analysisa Clones/Totalb Mutationc New Sequence
201 Brain Bulk No changes detected
201 SCd Bulk No changes detected
201 SC Clones 8/8 No changes detected
202 Brain Bulk No changes detected
202 SC Bulk 1544 (G to T) CSLWNVPHL
202 SC Clones 9/9 1544 (G to T) CSLWNVPHL
203 Brain Bulk No changes detected
203 SC Bulk No changes detected
204 Brain Bulk No changes detected
204 SC Bulk No changes detected
204 SC Clones 5/5 No changes detected
a Sequence of either bulk PCR product (bulk) or cDNA clones prepared from the PCR product (clones).
b Number of clones showing changes over total analyzed.
c Nucleotide change and location within sequence encoding epitope S-510–518 (nucleotides 1528–1554 of S gene).
d SC, spinal cord.
single MHV-infected rat has been reported (Morris et was the case, we harvested RNA from the brains of four
mice with acute encephalitis. Spinal cord samples wereal., 1989). As shown in Table 2, the same mutation was
present in RNA isolated from the brain and spinal cord not analyzed, since virus does not consistently spread
to the spinal cord by 6–7 dpi. cDNA was prepared andof three of the mice. In the fourth instance (mouse 163),
only wild-type sequence was detected in brain RNA, sequenced directly using PCR as described above. No
changes in epitope S-510–518 or in the adjoining se-suggesting that epitope S-510–518 was mutated solely
in the spinal cord. However, further analysis of RNA quence were detected in these samples. Since bulk se-
quence analysis of mouse brain 163 RNA showed thatisolated from the brain of this animal using cDNA clones
prepared from the bulk PCR product revealed that the only wild-type sequence was present (Table 2) while
clonal analysis revealed a significant number of quasi-population of S RNA sequences was very heteroge-
neous, with mutations at multiple sites present (Table species, 18 cDNA clones were sequenced from two of
the mice with acute encephalitis. In agreement with the2). Thus, the analysis of bulk PCR product detected the
predominant nucleotide at each position in the se- sequence analysis of bulk populations of cDNA, no
changes in the sequence encoding the epitope werequence of epitope S-510–518. The presence of a hetero-
geneous population of RNA molecules including wild- present (data not shown).
Mice that remain asymptomatic at 60 dpi rarely de-type sequence and the differences between brain and
spinal cord isolates suggest that mutations in the se- velop hindlimb paralysis thereafter (Jacobsen and Perl-
man, 1990; Perlman et al., 1987). Infectious virus cannotquence of the epitope arose independently from several
sites in the CNS. In addition, RNA encoding wild-type be isolated from asymptomatic mice, but viral antigen
can be detected in the brains and spinal cords of theseepitope S-510–518 could be detected in brain 163, unlike
any of the other samples from chronically infected mice. animals (Perlman et al., 1987). RNA was extracted from
the brains and spinal cords of four mice at 60 dpi andSince the CTL escape mutants should have a selective
advantage over wild-type virus, the presence of wild- cDNA was prepared. The cDNA product was sequenced
directly using PCR. With some of these samples, wetype sequence in brain 163 suggested that the process
of selection was in an earlier stage in this mouse. Consis- included a second PCR amplification step to obtain suf-
tent with this, mouse 163 developed symptoms at day ficient levels of DNA for sequencing. Sequence analysis
23, much earlier than the other animals analyzed in Table revealed no changes in epitope S-510–518 in three mice
2. It remains to be determined, however, precisely when (Table 3). In the fourth mouse, a significant change (gly-
CTL escape mutations first arise in MHV-infected mice. cine to valine at position 6) was detected. As shown
below, this change resulted in a loss of recognition by
CNS-derived lymphocytes. Because the results withMutations in Epitope S-510–518 Are Not Detected in
mouse brain 163 suggested that sequence analysis ofMice with Acute Encephalitis and Are Much Less
bulk PCR product could be misleading, we confirmedCommon in Mice That Remain Asymptomatic
these results for three of the four mice by sequencingat Late Times after Infection
cDNA clones (Table 3). These results suggest that muta-The results described above show that specific muta-
tions in epitope S-510–518 do not commonly occur intions can be detected in the sequence of epitope
mice that will, most likely, remain asymptomatic. How-S-510–518 in RNA isolated from mice with hindlimb pa-
ever, the results with mouse 202 suggest that significantralysis. If these changes are a result of immune selection
changes can sometimes be detected in asymptomaticand if they are important for increased viral replication
mice. Based on these results, we conclude that, in gen-and clinical disease, these mutations should not be
eral, mutations in epitope S-510–518 correlate with thepresent in mice with acute encephalitis, since thesemice
development of chronic demyelination and clinical dis-die at 6–7 days postinfection (dpi), soon after anti-MHV
ease, but that the presence of these mutations is notT cells can be detected in infected brains (Castro et al.,
1994; Williamson et al., 1991). To determine whether this sufficient for this process to occur.
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Figure 1. Stabilization of the H-2Db Molecule
on the Surface of RMA-S Cells
RMA-S cells were grown at 318C to induce
the expression of empty H-2Db molecules as
described in Experimental Procedures. The
ability of the indicated peptides to stabilize
cell surface expression of the H-2Db molecule
at 378C was determined. The peptides are
numbered according to which residue is mu-
tated (e.g., peptide 3 is mutated in residue 3).
Each peptide was analyzed in three indepen-
dent experiments with similar results. Data
are shown as the mean fluorescent intensity
measured on a log scale.
Variant Peptides Are Inefficiently Recognized shown in Figure 2, peptides with mutations in either
position 4 or 6 did not sensitize cells for lysis in thesein Direct Ex Vivo Cytotoxicity Assays
Using CNS-Derived Lymphocytes assays, while peptides with mutations in positions 3, 5,
or 7 were still recognized to some extent.The mutations described above result in amino acid
changes in epitope S-510–518. To determine whether The concentration of wild-type peptide S-510–518 re-
quired to sensitize target cells for half-maximal lysis wasmutations in epitope S-510–518 resulted in less efficient
recognition by CNS-derived lymphocytes, we synthe- approximately 20–100 pM when measured in cytotoxic-
ity assays using cells isolated from the brains of micesized peptides corresponding to five of the variant se-
quences and assayed them for their ability to bind to
the H-2Db molecule and to sensitize cells for lysis in
direct ex vivo cytotoxicity assays. Mutations in position
5 (peptide 5), the anchor asparagine residue, should
affect binding to the MHC class I molecule, whereas
mutations in positions 4, 6, or 7 (peptides 4, 6, or 7)
should primarily affect binding by the T cell receptor
(Gairin et al., 1995; Gairin and Oldstone, 1992; Young et
al., 1994). To identify which mutations in the peptide
affected binding, we analyzed the five peptides using
stabilization assays of the H-2Db molecule on the mutant
cell line RMA-S (Gairin and Oldstone, 1992; Jameson
and Bevan, 1992; Ljunggren et al., 1990; Schumacher
et al., 1990). These cells express low levels of empty
H-2Db molecules at the cell surface at 378C, but can be
induced to express high levels by growth at reduced
temperatures (198C–338C). Following transfer to 378C,
the H-2Db molecule rapidly disappears unless it is stabi-
lized by addition of exogenous peptide. The ability of a
peptide to stabilize the H-2Db molecule on the cell sur-
face correlates with its affinity for the molecule. When
the five peptides were analyzed in RMA-S stabilization
assays, the results shown in Figure 1 were obtained.
Peptides 3 and 5, mutated in residues 3 and 5, stabilized
the H-2Db molecule less efficiently than wild-type pep-
tide. In contrast, mutations in residues 4, 6, and 7 did
not reduce stabilization of the H-2Db molecule at 378C. Figure 2. Recognition of Wild-Type and Variant Peptides by CNS-
Next, the effects of these changes on recognition by Derived Lymphocytes
CTLs was determined. If the mutations in epitope Lymphocytes were harvested from the brains of mice with acute
encephalitis and analyzed in direct ex vivo cytotoxicity assays usingS-510–518 are biologically significant, peptides con-
the indicated peptides at a final concentration of 1 mM as previouslytaining these changes should be recognized less effi-
described (Castro and Perlman, 1995). The effector to target ratiociently by MHV-specific CD81 T cells. In previous reports
was 50:1. Spontaneous release was <10%. Only peptides 3, 5, and(Castro et al., 1994; Castro and Perlman, 1995), S-spe-
7 sensitized EL-4 cells for lysis above background (background is
cific CD81 T cells were analyzed using lymphocytes har- uncoated EL-4 cells [NONE]). Each peptide was analyzed in three
vested from the CNS of infected mice in direct ex vivo to nine independent experiments. The mean of percent specific lysis
for all experiments is shown. Bars show standard error.cytotoxicity assays without any stimulation in vitro. As
Immunity
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Figure 3. Cytotoxic Response of CNS-
Derived Lymphocytes to Different Concentra-
tions of Wild-Type and Variant Peptides
The figure shows the CTL response to the
three peptides (peptide numbers 3, 5, and 7)
that sensitized EL-4 cells for lysis by CNS-
derived lymphocytes in Figure 2. Significantly
more variant than wild-type peptide was re-
quired to sensitize cells for lysis.Approximate
concentration required for half-maximal lysis:
wild-type peptide, 20–100 pM; variant pep-
tides, 10–40 nM. Each peptide was analyzed
in four independent experiments with similar
results.
with acute encephalitis (Figure 3; see also Castro and mice protected by maternally derived antibodies, and it
is theoretically possible that they were antibody ratherPerlman, 1995). In the assays shown in Figure 2, pep-
tides were used at a final concentration of 1 mM, a than CTL escape mutants. However, in a previous study
employing several viruses isolated from mice with hind-vast excess over the minimum required for half-maximal
sensitization. To determine whether concentrations of limb paralysis, we showed that there was no evidence
for antibody escape using a panel of anti-S monoclonalvariant peptides 3, 5, and 7 higher than that of wild-type
peptide were required to sensitize cells for recognition antibodies (Perlman et al., 1990) in an enzyme-linked
immunosorbent assay. In addition, these changes wereby CD81 T cells, we performed dose response experi-
ments (Figure 3). At least 100-fold more variant peptide not likely to result from CD41 T cell selection, since no
CD41 T cell epitope is present in this part of the S proteinwas required to sensitize EL-4 target cells for lysis by
CNS-derived lymphocytes. Peptide 5 was particularly (unpublished data). Thus, it seems most likely that CD81
T cell–driven immune pressure accounted for theinteresting. Although at a concentration of 1 mM it sensi-
tized cells for lysis nearly as well as wild-type peptide, changes that we have documented. We cannot, how-
ever, formally eliminate the possibility that additionalit quickly lost activity at lower concentrations. This pep-
tide, mutated in the anchor residue at position 5, proba- mutations in other parts of the genome have arisen con-
currently and that the changes in epitope S-510–518 arebly bound poorly to the MHC class I molecule, but once
bound (which occurred at large peptide excess) was incidental to the development of clinical disease.
Second, changes were not detected in mice with acuterecognized by anti-MHV CD81 T cells. At lower concen-
trations, binding of peptide 5 to the MHC class I mole- encephalitis, suggesting that the changes arose during
the course of virus persistence. In mice that remainedcule no longer occurred. Similar results have been re-
ported for mutations in the anchor residue of an asymptomatic at 60 dpi, changes in epitope S-510–518
were detected in one of four mice analyzed. This changeimmunodominant hepatitis B epitope (Bertoletti et al.,
1994a). From these experiments, we conclude that mu- (glycine to valine at position 6) was also detected in mice
with hindlimb paralysis and caused a lack of sensitiza-tations in epitope S-510–518, which occur during persis-
tence in the mouse, result in complete or partial loss of tion for T cell lysis (Figure 2). Since mice only rarely
develop hindlimb paralysis after 60 dpi (Jacobsen andrecognition by CD81 T cells specific for that epitope.
Perlman, 1990; Perlman et al., 1987), this most likely
shows that other factors besides changes in the epitopeDiscussion
are required for virus escape and the development of
clinical disease. Third, all of the changes were nonsyn-For a period of several weeks, mice infected at the suck-
ling stage with MHV-JHM and protected from acute en- onymous and resulted in significant changes in the
amino acid sequence. Fourth, the significance of thesecephalitis by nursing with dams immunized to the virus
remain asymptomatic. However, a variable percentage changes was demonstrated in direct ex vivo cytotoxicity
assays using lymphocytes derived from the brain andthen develop a symptomatic demyelinating encephalo-
myelitis, and virus can be isolated from these mice. The spinal cord. Since bulk populations of cells were used
in these assays, the results suggested that most of theresults reported here are consistent with the notion that
this relatively abrupt onset of clinical disease is largely epitope S-510–518–specific T cells could not recognize
variant peptide and therefore were biologically signifi-due to the development of mutations in a strong CD81
T cell epitope. First, analysis of samples of infectious cant. Some of the changes were in residues (e.g., posi-
tions 4, 6, and 7) important for binding by the T cellvirus and RNA isolated from diseased mice showed that
nearly all were mutated specifically and solely in epitope receptor (Gairin et al., 1995; Gairin and Oldstone, 1992;
Young et al., 1994). It was not, therefore, anticipatedS-510–518. No other mutations were consistently de-
tected. These variant viruses were initially isolated from that changes in these residues would have such a major
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effect on CTL recognition, since a polyclonal CD81 T or C57Bl/10 background predispose mice to the devel-
opment of hindlimb paralysis. Whether mutations incell response should include T cell receptors with a
wide range of fine specificity for epitope S-510–518. the H-2Kb-restricted S-specific epitope or the H-2Ld-
restricted N-specific epitope occur in infected B10.AA possible explanation is that the T cell response is
oligoclonal in MHV-infected mice, as has been de- (18R) mice remains to be determined.
Previous studies in HIV-infected patients suggestedscribed in other settings (Casanova and Maryanski,
1993; Hingorani et al., 1996; Kalams et al., 1994; Maryan- that changes in CTL epitopes occurred as a result of
immune pressure (Miedema and Klein, 1996; Phillips etski et al., 1996; Pantaleo et al., 1994).
Several other features of these data are noteworthy. al., 1991; Wolinsky et al., 1996). Changes in viral se-
quence were frequent in the presence of a strong CTLThe changes that we detected were confined to one or
two amino acids in this region of the S protein in any response and were less frequent in the absence of such
a response. Similar conclusions were reached in a studysingle mouse and probably did not affect virus virulence.
In support of this, we showed previously that the virus of chronic hepatitis B carriers (Bertoletti et al., 1994a;
Rehermann et al., 1995). Our results are in agreementisolated from two mice with hindlimb paralysis was ap-
proximately as virulent as the original inoculum (Perlman with these studies, since the changes that we detected
occurred in the presence of a strong CTL response.et al., 1990). The retention of virulence isprobably critical
for the increase in virus replication observed, since virus The residual CTL response to other epitopes, including
epitope S-598–605, clearly was unable to control virusthat became attenuated during the course of persis-
tence might not be able to replicate to high levels in the replication in these persistently infected mice. The re-
sults also demonstrate that CTL escape mutants arepresence of the residual immune response. Of note,
many models of MHV persistence use attenuated virus, especially significant when the ability of the host to con-
trol a persistent virus infection is tenuous and their emer-and while these viruses cause demyelination, mice usu-
ally remain asymptomatic or show mild signs of nonpro- gence tips the balance to the pathogen, resulting in this
case in a chronic demyelinating disease.gressive clinical disease at later times after inoculation.
With rare exceptions, infectious virus cannot be isolated
Experimental Proceduresfrom mice infected with attenuated variants later than
1–3 weeks postinfection, again suggesting that virus
Virusmust remain virulent to escape from the host immune
MHV-JHM, used in all studies, was grown and titered as previously
response and exhibit increased replication at later times described (Perlman et al., 1987). To obtain virus from chronically
after infection (Knobler et al., 1982; Kyuwa and Stohl- infected mice, brains and spinal cords were removed from mice with
man, 1990; Lavi et al., 1984). hindlimb paralysis and sonicated in Dulbecco’s minimum essential
medium. After removal of large debris by centrifugation, samplesThe conditions for the development of CTL escape
were passaged at a 1:10 dilution through BALB/c 17CL-1 cells ormutants are particularly favorable in the part of the S
DBT cells (a murine astrocytoma cell line). Virus from passages 1–3gene encompassing epitope S-510–518. Deletions in
was used in all studies.
the region encompassing, approximately, nucleotides
1300–1800 of the S gene are not lethal and appear to Animals
be readily incorporated into infectious virus (Banner et Pathogen-free B6 mice were purchased from Jackson Laboratories
(Bar Harbor, ME) and Harlan Sprague Dawley (Indianapolis, IN).al., 1990; Parker et al., 1989). Although the entire epitope
and its flanking sequences are included in this hypervari-
Peptidesable region, only mutations in the actual epitope were
Peptides were either obtained from Chiron Mimotypes (Clayton,
detected. Mutations insequences flanking defined CD81 Victoria, Australia) as previously described (peptide corresponding
T cell epitopes, believed to affect peptide transport or to wild-type sequence) (Castro and Perlman, 1995) or synthesized
processing, have been detected in virus isolated from by the Protein Structure Facility at the University of Iowa using
manual solid-phase synthesis with protection of the a-amino groupsHIV-infected patients (Couillin et al., 1994). Mutations in
by 9-fluorenylmethoxycarbonyl (wild-type and variant peptides). Ac-flanking sequences have also been shown to affect CTL
tivation of the amino acid was accomplished using HBTU/HoBt.recognition by influenza-specific CTLs (Eisenlohr et al.,
Cleavage of the peptide from the resin and simultaneous removal
1992). Such mutations were not detected in our study. of the side chain protecting groups was accomplished using a mix-
Similarly, no evidence for changes in the flanking se- ture of trifluoroacetic acid and scavengers. Peptides were purified
quences were reported in a study of in vivo selected by high pressure liquid chromatography using a C18 reverse-phase
column. The identity of the purified peptide was confirmed using aLCMV variants resistant to CTL lysis (Pircher et al.,
Voyager matrix-assisted laser desorption ionization time-of-flight1990).
mass spectrometer.Factors other than escape from the immunodominant
CTL response to epitope S-510–518 may also play a
Isolation of RNA from Infected CNS Tissue
role in the development of hindlimb paralysis at late and Tissue Culture Cells
times after infection. B10A.(18R) mice (KbDdLd) lack the RNA was isolated from infected brains and spinal cords using the
H-2Db-restricted response to epitope S-510–518, but guanidinium isothiocyanate–cesium chloride method as previously
described (Perlman et al., 1990). RNA was isolated from infectedexpress a strong Ld-restricted response to the nucleo-
DBT cells using Tri Reagent (Molecular Research Center, Cincinnati,capsid (N) protein. Unlike BALB/c mice, B10A.(18R) mice
OH) according to the specifications of the manufacturer.also develop hindlimb paralysis, although at a lower
frequency than B6 or C57Bl/10 mice (Castro et al., 1994). Sequence Analysis
Since both BALB/c and B10A.(18R) mice express an In all cases, cDNA was synthesized from 2 mg of infected tissue or
immunodominant response to the N protein, this tissue culture cell RNA. For cDNA synthesis, the RNA was incubated
at 408C for 60 min in a 30 ml reaction containing 50 mM Tris–HClsuggests that other genetic factors present in the B6
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(pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM DTT, 0.3 mM each of dispersion of the tissue, Percoll (Pharmacia, Uppsala, Sweden) was
added to a final concentration of 30%.The lysate was spun at 1300 3dNTP, BSA (final concentration 0.1 mg/ml), 40 U of RNasin (Pro-
mega, Madison, WI), 1 mg of random hexamer oligonucleotides g for 30 min at 48C. The Percoll and lipid layers were aspirated, and
the cell pellet was washed twice and counted.(Pharmacia Biotech, Piscataway, NJ), and 200 U of Superscript
M-MLV reverse transcriptase (Bethesda Research Laboratories,
Gaithersburg, MD). The synthesized cDNA was amplified by PCR Direct Ex Vivo Cytotoxicity Assays Using
using standard techniques. In brief, 5 ml of the reverse transcription CNS-Derived Lymphocytes
mixture was mixed with 45 ml of a master mix containing 10 mM Peptides were tested for their ability to sensitize EL-4 cells for lysis
Tris–HCl (pH 9.0), 50 mM KCl, 0.1% Triton X-100, 1.5 mM MgCl2, by CNS-derived lymphocytes as previously described (Castro and
0.2 mM dNTP, 1 mM synthetic oligonucleotide primers, and 2.5 U Perlman, 1995). The average spontaneous release for the EL-4 cells
of Taq polymerase (Promega). The reaction mixture was subjected was <10%.
to 25 cycles of amplification, with each cycle consisting of 948C for
30 s, 558C for 30 s, 728C for 30 s. At the end of these cycles, an Acknowledgments
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